Ligand validation:6ARJ

BW4: methyl 2-[2-{2-chloro-5-[(2R)-2-hydroxy-3-(methylamino)propoxy]phenyl}-6-(3,5-dimethyl-1,2-oxazol-4-yl)-5-methylpyrimidin-4-yl]-2,7-diazaspiro[3.5]nonane-7-carboxylate

BW4 is a Ligand Of Interest in 6ARJ designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
6ARJ_BW4_B_502	84%	10%	0.104	0.965	2.38	2.13	5	15	0	0	100%	0.5
6ARJ_BW4_D_502	81%	11%	0.102	0.953	2.52	1.92	5	15	0	0	100%	0.5
6ARJ_BW4_C_502	80%	9%	0.108	0.956	2.62	2	6	14	0	0	100%	0.5
6ARJ_BW4_A_502	71%	11%	0.129	0.95	2.44	2	5	14	0	0	100%	0.5

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM133198.